Page results
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
Today, this National Day of Reflection, we remember those members of staff who we sadly lost due to COVID-19.
-
This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.
-
Court of Appeal has ruled in favour of the Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS).
-
Learn more about how UCLH celebrated Research Open Day this month.
-
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
-
London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.
-
This page tells you about the procedure known as a Bronchial Artery Embolisation (BAE).
-
The video-assisted stroke triage project, developed by the UCLH stroke service in partnership London Ambulance Service (LAS) has won the HSJ Patient Safety Award for Clinical Governance & Risk Management in Patient Safety.
-
UCH Chemotherapy Daycare and the Macmillan Support and Information Service are shortlisted for a Patient Experience Network National Award for the use of data from the Cancer Patient Experience Survey to improve patient experience.
File results
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0516 - Maternity management system
-
FOI/2023/0514 - Processes and software applications used in Urology
-
FOI/2023/0491 - Treatment for oesophageal and gastric cancer
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0493 - Treatments for various diseases
-
FOI/2023/0499 - Treatments for non-small cell lung cancer
-
FOI/2023/0488 - Electronic Patient Record (EPR)
-
FOI/2023/0487 - Maintenance of corporate estate